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A B S T R A C T   
The global pandemic of coronavirus disease 2019 (COVID-19) is continuing to have a significant effect on the 
well-being of the global population, thus increasing the demand for rapid testing, diagnosis, and treatment. As 
COVID-19 can cause severe pneumonia, early diagnosis is essential for correct treatment, as well as to reduce the 
stress on the healthcare system. Along with COVID-19, other etiologies of pneumonia and Tuberculosis (TB) 
constitute additional challenges to the medical system. Pneumonia (viral as well as bacterial) kills about 2 
million infants every year and is consistently estimated as one of the most important factor of childhood mor-
tality (according to the World Health Organization). Chest X-ray (CXR) and computed tomography (CT) scans are 
the primary imaging modalities for diagnosing respiratory diseases. Although CT scans are the gold standard, 
they are more expensive, time consuming, and are associated with a small but significant dose of radiation. 
Hence, CXR have become more widespread as a first line investigation. In this regard, the objective of this work is 
to develop a new deep transfer learning pipeline, named DenResCov-19, to diagnose patients with COVID-19, 
pneumonia, TB or healthy based on CXR images. The pipeline consists of the existing DenseNet-121 and the 
ResNet-50 networks. Since the DenseNet and ResNet have orthogonal performances in some instances, in the 
proposed model we have created an extra layer with convolutional neural network (CNN) blocks to join these 
two models together to establish superior performance as compared to the two individual networks. This strategy 
can be applied universally in cases where two competing networks are observed. We have tested the performance 
of our proposed network on two-class (pneumonia and healthy), three-class (COVID-19 positive, healthy, and 
pneumonia), as well as four-class (COVID-19 positive, healthy, TB, and pneumonia) classification problems. We 
have validated that our proposed network has been able to successfully classify these lung-diseases on our four 
datasets and this is one of our novel findings. In particular, the AUC-ROC are 99.60, 96.51, 93.70, 96.40% and 
the F1 values are 98.21, 87.29, 76.09, 83.17% on our Dataset X-Ray 1, 2, 3, and 4 (DXR1, DXR2, DXR3, DXR4), 
respectively.   
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1. Introduction 
Coronavirus 2019 (COVID-19), a disease caused by severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, has affected 
the health of populations globally (Gorbalenya et al., 2020). In order to 
control the COVID-19 pandemic, there is an urgent need for rapid and 
accurate diagnostic testing in healthcare (Cheng et al., 2020; Tang et al., 
2020). Since SARS-CoV-2 can cause COVID-19 pneumonia and severe 
lung damage, differentiating viral from bacterial pneumonia and other 
respiratory infections such as Tuberculosis (TB) using chest imaging 
technology is essential for managing infection control decisions and 
diagnosis and for planning treatment regimes (Qin et al., 2019). 
Many infectious respiratory diseases present in a similar manner, 
with symptoms such as difficulty in breathing, persistent cough, and 
fever. Pneumonia, an infection affecting the airspaces in the lung, is 
caused by various etiological agents such as bacteria, viruses, and fungi. 
There is a wide range of symptoms associated with the infection, which 
include shortness of breath, fever, phlegm production, and cough. The 
progression of the disease is marked by the air space opacification, 
which can be detected using imaging diagnostics (Suzuki et al., 2019; 
Reittner et al., 2003). Despite the availability of antimicrobials, pneu-
monias contribute to the most common cause of mortality, especially in 
childhood (World Health Organization, 2011). In addition, TB induces a 
persistent cough and breathlessness with symptoms that overlap those of 
pneumonia and COVID-19. The mortality rates have also risen due to 
drug-resistant pulmonary TB, caused by Mycobacterium tuberculosis 
(World Health Organization, 2020). There is therefore a clear need for a 
robust artificial intelligence (AI) system that can detect and classify the 
various respiratory diseases that have overlapping presentations to the 
clinic, so that the right course of treatment regime can be prescribed. 
The standard imaging modalities for lung disease diagnosis include 
magnetic resonance imaging (MRI), chest X-ray (CXR), and computed 
tomography (CT) scan. Although MRI and CT scan are the gold standard 
for assessing lung diseases, they are more expensive, involve radiation 
exposure, and are not readily available globally (Soltan et al., 2020). In 
comparison, CXR is less expensive, readily available, and is one of the 
most common diagnostic imaging techniques for cardiothoracic and 
pulmonary disorders. 
CXR patterns of lung disease present differentiation challenges and 
often result in high inter-reader variability across radiologists (Williams 
et al., 2013). With potential future waves of the pandemic, radiologists’ 
workloads will increase and there is an urgent need for new automated 
image analysis tools that can enhance the radiologists’ qualitative 
assessment. These tools will classify or segment sections of the CXR in 
order to support the diagnostic workflow. Decision support systems are 
designed to aid the clinical decision-making process and have estab-
lished themselves as emerging research trend in healthcare (Stacey 
et al., 2017). Over recent months of the pandemic, automated detection 
of pneumonia or other lung diseases, specifically their early detection 
and classification, have gained significant attention from both clinical 
and the AI researchers. 
The development of AI-based medical systems, as well as their 
translation to medical practice, is playing an increasingly prominent role 
in the treatment and therapy of patients (Greenspan et al., 2020). Along 
with the automated methods that rely on the blood test results or bio-
markers for diagnosis (Banerjee et al., 2020; Song et al., 2020a; Lal-
muanawma et al., 2020), an increasing number of deep learning-based 
methods, specifically the convolution neural network (CNN)-based 
models (Pereira et al., 2020; Das et al., 2020; Sarker et al., 2020; Li et al., 
2020a; Ozturk et al., 2020a), are being implemented and used in order 
to develop accurate, robust, and fast detection techniques to fight 
against COVID-19 and other respiratory diseases. 
In this regard, the aim of the current study is to test the feasibility of 
early automated detection and distinction between COVID-19, pneu-
monia, TB, and healthy patients based on CXR scans. We have developed 
a deep transfer learning pipeline, named DenResCov-19, to diagnose if a 
patient is healthy or has a lung disease. The proposed network optimally 
combines the DenseNet-121 and ResNet-50 networks. This combination 
unifies the simplicity of ResNet structure and the complexity of Dense-
Net blocks and delivers a well-balanced result of accuracy and increased 
specificity and sensitivity. Pretrained networks on the ImageNet cohort 
are used as transfer learning techniques. We have tested the adaptability 
of our proposed network for two-class (pneumonia and healthy), three- 
class (COVID-19 positive, pneumonia, and healthy), as well as four-class 
(COVID-19 positive, pneumonia, TB, and healthy) classification prob-
lems. To the best of our knowledge, this is the first work to examine the 
feasibility of early automatic detection and distinction between COVID- 
19 positive, pneumonia, TB, and healthy patients based only on CXR 
scans using a deep-learning (DL) network. The proposed DenResCov-19 
network has been able to perform optimally in different multi-class 
problems and has achieved robust and improved performance over the 
state-of-the-art methods for the classification of lung-diseases in all our 
datasets. The main contributions of this paper are as follows:  
1. The development of a new deep-learning network, named 
DenResCov-19, for robust and accurate classification. 
2. Evaluating the accuracy and robustness of DenResCov-19 over het-
erogeneous CXR image datasets with binary and multi-class labels 
(COVID-19, pneumonia, TB, and healthy).  
3. Evaluating the robustness of DenResCov-19 network over a Monte 
Carlo cross validation scheme for multi-class classification.  
4. The comparison of DenResCov-19 with established networks of 
ResNet-50, DenseNet-121, VGG-16, and Inception-V3.  
5. Developing a pre-screening fast-track decision network to detect 
COVID-19 and other lung pathologies. 
The rest of the paper is organized as follows: Section 2 gives a brief 
overview of the related works. Section 3 presents the development of the 
proposed methodology, while Section 4 summarizes its implementation 
and the description of clinical datasets. Numerical results of the appli-
cation of our method on four different datasets are presented in Section 
5. The final conclusions are presented in Section 6. 
2. Related works 
In this section, we present a brief overview of pneumonia and 
COVID-19 diagnosis studies based on CXR/CT scans and the impact of 
artificial intelligence in clinical management of COVID-19. 
2.1. Review of pneumonia detection in CXR images 
There exists a significant body of literature on the application of deep 
learning networks on CXR images for detecting pneumonia in patients 
(Bustos et al., 2020; Jaiswal et al., 2019; Varshni et al., 2019; Varela--
Santos and Melin, 2021). Here we give a summary of the most important 
approaches. 
Jaiswal et al. (2019) used Mask-Region-based CNN (He et al., 2017) 
model to automatically identify potential pneumonia cases from CXR 
images. Bharati et al. (2020) proposed a hybrid deep learning frame-
work by combining VGG (Ozturk et al., 2020b), data augmentation, and 
spatial transformer network (STN) with CNN. They trained their model 
in NIH CXR dataset (Kermany et al., 2018) with 73% accuracy. Even 
though their approach did not achieve a high accuracy, their network 
required training time of only 431 s on their full dataset. Bustos et al. 
(2020) presented a comprehensive study on a significantly large dataset 
of 160,000 CXR images, including 19 different classes of lung diseases. 
They compared four models, namely CNN, recurrent neural network 
(RNN) composed of bi-directional long short-term memory (LSTM) cells 
(Hochreiter and Schmidhuber, 1997), CNN with per-label attention 
mechanism (CNN-ATT) (Mullenbach et al., 2018), and RNN composed 
of bi-directional LSTM cells with per-label attention mechanism 
(RNN-ATT). Among the four models, the RNN-ATT model achieved the 
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best results with 86.4% accuracy with only 41 epochs training. Vare-
la-Santos and Melin (2021) implemented an automated system for 
future detection of COVID-19 and pneumonia diseases in CXR and CT 
lung images. They efficiently utilized the image texture feature de-
scriptors from CXR images in feed-forward and convolutional neural 
networks for detecting COVID-19, pneumonia, and healthy individuals. 
2.2. Review of COVID-19 detection in CXR and CT images 
Prior to COVID-19, deep learning (DL) models have been used 
extensively for the classification of pneumonia and other lung diseases. 
Following their successes, a range of DL approaches have been devel-
oped for diagnosing and differentiating COVID-19 lung infections (He 
et al., 2021; Gilanie et al., 2021). Most of these new approaches are 
based on CXR and CT modalities, which are the most widely used im-
aging modalities for diagnosing pneumonia and COVID-19 (Das et al., 
2020; Sarker et al., 2020; Li et al., 2020a). Here we review the perfor-
mance of some of these studies. 
Ozturk et al. (2020a) proposed the DarkCovidNet model to assist 
clinicians and radiologists to diagnose COVID-19. Their network, 
inspired by DarkNet, achieved accuracy of 98.08% and 87.02% 
respectively, for binary (COVID-19 vs healthy) and multi-class classifi-
cation (COVID-19, pneumonia or healthy). DarkCovidNet is based on 
the DarkNet, which is good for fast performance (e.g., with self-driving 
cars); but in our case, time is not really a critical issue. Moreover, the 
network was only tested on a limited number of cases. Larger datasets 
will be able to test its robustness. 
Pereira et al. (2020) designed the network model RYDLS-20, that 
achieved F1 value of 89% for COVID-19 diagnosis. Their dataset was 
highly imbalanced, with 1000 healthy cases and 90 patients affected by 
COVID-19. More importantly, their classification performance was 
presented without any cross-validation step. 
Yoo et al. (2020) proposed a combination of three decision-tree 
classifiers for pre-screening fast-track decision making in order to 
detect COVID-19. Their pipeline was a combination of three binary 
decision trees, each trained by a deep learning model with CNN. The 
accuracies of the binary decision trees ranged between 80% and 98%. 
However, their network did not test any pathologically confirmed data. 
In addition, they did not incorporate any data augmentation technique 
during training in order to reduce the overfitting effects. A large dataset 
of 5000 CXR scans was used by (Minaee et al., 2020) for classification of 
healthy and COVID-19 cases. They used four different models, including 
ResNet18 (He et al., 2016), ResNet50 (He et al., 2016), SqueezeNet 
(Iandola et al., 2016), and DenseNet-161 (Huang et al., 2017), and 
achieved on average sensitivity of 98% and specificity of 92%. 
Another set of studies have presented satisfactory outcomes in the 
classification of COVID-19 and healthy cases from CT images (Chen 
et al., 2020; Harmon et al., 2020; Li et al., 2020b; Song et al., 2020b; 
Wang et al., 2020). Li et al. (2020b) studied CT images deployed at 
sixteen different hospitals. They used a U-net to first segment the lung 
regions and then applied a ResNet-50 to classify the patient as COVID-19 
affected or not. Their pipeline achieved a good accuracy, because there 
was no noise in peripheral organ regions due to the segmentation of 
lungs. One of the limitations of their study is that their dataset had 
higher number of positive cases that made the prediction biased 
(723/1136). However, the major achievements of this study are the 
incorporation of inter-hospital variations in datasets and the use of six 
independent experts to arrive at the ground truth. 
In another study, Li et al. (2020a) used statistical methods, which 
included ‘total severity score’ to classify healthy and unhealthy patients 
based on CXR images. The authors applied the Wilcoxon-rank test to 
predict the level of severity of the patients. They computed their ground 
truth using inter-scan and inter-observer variability and also provided 
thorough details on how the severity level was computed. However, 
their severity dataset was not large enough and also, they did not 
incorporate any data splitting based on advanced age, underlying 
diseases, and pleural effusions. 
Song et al. (2020b) implemented a deep learning-based CT diagnosis 
system, named Deep-Pneumonia, to identify patients with COVID-19. 
They manually segmented the lung region and then classified 
COVID-19 or healthy cases using a DL network. This network, named 
DRE-Net, is a combination of ResNet-50, feature pyramid network 
(FPN), and an attention module. The main advantages of this study are 
the multi-vendor datasets from three different hospitals, the very high 
sensitivity (95%) and specificity (96%) values, and the fast diagnosis 
time per patient (30 s). However, its drawbacks include: the need of 
semi-automatic lung segmentation, the classification of datasets based 
only on CT images without any splitting depending on advanced age, 
underlying diseases, or pleural effusions, and the absence of any refer-
ence in inter-observer variability of the ground truth. 
Chen et al. (2020) trained their deep network using 46,096 anony-
mous images from 106 admitted patients, including 51 patients with 
laboratory confirmed COVID-19 pneumonia and 55 control patients 
with other diseases, in Renmin Hospital of Wuhan University. They used 
a U-net++ network to segment the lungs and classified whether the 
region had a scar area. The two-tailed paired Student’s t-test with 0.05 
significance level was used for time comparison between radiologist and 
the model. The key advantages of this study include: the large and 
well-balanced training dataset, the high classification accuracy (over 
95%), and the use of three expert radiologists accounting for the 
inter-observer variability to extract the ground truth. The main limita-
tions of this study were that the dataset was collected from only one 
hospital and the classification was based only on CT images without any 
data-splitting based on advanced age, underlying diseases, or pleural 
effusions. Also, their lung segmentation step, being in a new cohort, can 
potentially decrease the total classification accuracy. 
2.3. Review of artificial intelligence in clinical management of COVID-19 
pandemic 
During the global pandemic of COVID-19, a lot of different problems 
were introduced from the scientific community. Greenspan et al. (2020) 
highlighted the importance of artificial intelligence (AI) (Chassagnon 
et al., 2021) in the early disease detection, the severity risk management 
of COVID-19 disease in the hospitals, and the importance of imple-
mented patient-specific predictive models based on imaging and addi-
tional clinical features. 
Regarding the early stage of COVID-19 detection, Gao et al. (2021) 
implemented a segmentation-classification network to classify 
COVID-19 or healthy patient. They used a cross-institute protocol vali-
dation of internal and external validation datasets. Di et al. (2021) 
implemented hypergraph learning to classify COVID-19 or community 
acquired pneumonia (CAP) from CT imaging. They used a multi-center 
dataset of 3330 CT images with COVID-19 and CAP cases. A combina-
tion of weakly supervised active learning, 2D U-Net and a 3D residual 
network by Wu et al. (2021) delivered impressive results of the lung 
region segmentation and COVID-19 detection. 
The severity risk level of COVID-19 pathologies was studied by Zhu 
et al. (2021) and Xue et al. (2021). Zhu et al. (2021) proposed a joint 
classification and regression method to determine the severity level and 
the conversion time for patients. Xue et al. (2021) introduced a severity 
detection of COVID-19 based on lung ultrasound and clinical features. 
Even though the above studies including the works by Yang et al. 
(2021) and Goncharov et al. (2021) delivered impressive robust and 
accurate results of binary COVID-19 classification, the lack of use of 
networks to predict multi-class classification of different lung pathol-
ogies (including COVID-19) is still a main challenge. 
2.4. Limitations of the existing studies 
As discussed, some studies have attempted to solve the problem of 
automated diagnosis of pneumonia and COVID-19, based on existing 
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deep learning networks (Minaee et al., 2020; Ozturk et al., 2020a; Per-
eira et al., 2020) on CT (Chen et al., 2020; Harmon et al., 2020; Li et al., 
2020b; Song et al., 2020b; Wang et al., 2020) or on CXR (Ozturk et al., 
2020a; Yoo et al., 2020; Das et al., 2020; Li et al., 2020a; Sarker et al., 
2020) image cohorts. However, the noted algorithms suffer from the 
following limitations and challenges:  
1. The lack of regularization techniques (data augmentation, penalty 
norms, etc.) used in models to avoid possible overfitting.  
2. Lack of balance in the models between the speed and the robustness 
and accuracy.  
3. The lack of generalization techniques, such as cross-validation, for 
accurate predictions of the models.  
4. The need of manual segmentation of the lung region from experts to 
deliver a robust semi-automatic classification result.  
5. The validation of the models for only binary classification (Minaee 
et al., 2020; Pereira et al., 2020; Yoo et al., 2020; Gao et al., 2021; 
Chassagnon et al., 2021) or three-class (COVID-19, pneumonia, and 
healthy) classification tasks (Ozturk et al., 2020a; Das et al., 2020; Li 
et al., 2020a; Sarker et al., 2020).  
6. The validation of the models in one specific cohort (i.e. no cross- 
vendor or cross-institute validation). 
3. Methodology and background 
In the current study, we propose to train a deep learning network, 
named DenResCov-19, to solve a multi-class problem, namely, whether 
a patient is healthy or has pneumonia, COVID-19, or tuberculosis. 
3.1. Background 
Our approach is based on two state-of-the-art networks: ResNet (He 
et al., 2016) and DenseNet (Huang et al., 2017). They have recently been 
used to solve similar multi-class problems. 
ResNet-L is inspired by the structure of VGG nets (Simonyan and 
Zisserman, 2015). The network comprises of L layers, each of which 
implements a non-linear transformation. In the majority of 
ResNet-based networks, the convolutional layers have 3 × 3 filters. 
Downsampling is performed by convolutional layers with a stride of 2. 
The last two layers of the network are an average pooling layer, followed 
by a 1000-way fully-connected (FC) layer. The main rule of this deep 
network is that the layers have the same number of filters as the number 
of the output feature map size. In case the feature map size is halved, the 
number of filters is doubled, thus reducing the time complexity per 
layer. CNN feed-forward inputs xi are the outputs xi− 1 of the previous 
layer, so the transition layer is given by xi = Hi(xi− 1). In particular, 
ResNet adds a skip-connection and the identity function is given by: 
xi = Hi(xi− 1) + xi− 1 (1) 
DenseNet-L is a convolutional network. The network comprises of L 
layers, each of which implements a non-linear transformation. These 
transformations can be different function operations, such as Batch 
Normalization, rectified linear units (ReLU), Pooling, and Convolution. 
Huang et al. (2017) introduced a unique connectivity pattern informa-
tion flow between layers to direct connecting any layer to all subsequent 
layers. As a result, the ith layer includes the feature-maps of all previous 
layers. The input of ith layer is given by the equation: 
xi = Hi([x0, x1,⋯ , xi− 1]) (2)  
where [x0, x1, ⋯ , xi− 1] refers to the concatenation of the feature-maps 
produced in layers 0, …, i− 1. All inputs of a composite function Hi(⋅) are 
concatenated into a single tensor. Each composite function is a combi-
nation of batch normalization (BN), followed by a rectified linear unit 
(ReLU) and a 3 × 3 convolution (Conv). 
3.2. Network architecture 
To evaluate the state-of-the-art networks before we train and test 
them in the CXR cohorts, we initially test them in the open-source and 
widely used CT cohort of Zhao et al. (2020). Since there is currently a 
lack of existing publicly available dataset of CXR images relating to 
COVID-19 cases, we have tested the behavior of benchmark models in 
the CT cohort in order to check if the expected behavior of the proposed 
network can be observed (i.e. achieve high F1 and AUC-ROC values). 
Table 1 highlights the results of DenseNet-121, ResNet-50, and VGG- 
16 networks for classification of pneumonia, COVID-19, and healthy 
cases in CT images. From the results, it can be observed that, while the 
ResNet has better precision, recall, and F1 metrics than the DenseNet, 
DenseNet has better AUC-ROC. ResNet also achieves higher precision, 
AUC-ROC, and F1 metrics than the VGG, while VGG attains higher recall 
values. Based on these observations, we hypothesize that a combination 
of the two models, ResNet and DenseNet, can deliver a well-balanced 
AUC-ROC and F1 metric results. 
The architecture of our proposed DenResCov-19 network is pre-
sented in Fig. 1. DenResCov-19 network is a concatenation of four blocks 
from ResNet-50 and DenseNet-121 with width, height, and frames of 
58 × 58 × 256, 28 × 28 × 512, 14 × 14 × 1024, and 7 × 7 × 2048, 
respectively. We chose these specific blocks from the networks, as we 
needed layers with the same width × height × frames, so that the in-
formation of both models can be combined. As a result, we used four 
different layers of 58, 28, 14, and 7 size kernels, as we wanted to 
concatenate the information of the two networks in different regions of 
interest. Each of the four outputs feed a block of convolution and 
average pooling layers. Thus, the initial concatenated information can 
be translated into the convolution space. After that, we used some levels 
of concatenation-CNN block techniques to create kernels that will 
deliver a final layer of soft-max regression, so that the network can 
conclude in the classification decision. 






ωabyl− 1(i+a)(j+b), (3)  
where xli,j is a unit in layer l, ωab is an M × M filter, and yl− 1(i+a)(j+b) is the 
nonlinearity of previous convolutional layer given by: 
ylij = σ(xlij). (4) 
The average pooling layer is defined over a K × K region and outputs 
a single value, which is the average over that region. The inputs of the lth 













+ xresl− 1, (5)  
where Hresl (⋅) is the composite function of lth ResNet layer and H
des
l (⋅) is 
composite function of lth DenseNet layer. The last step of the pipeline is 
the combination of two pair concatenation and a global concatenation 
followed by a 512-way fully-connected softmax layer. 
Table 1 
Metrics of deep learning networks to classify pneumonia, COVID-19, and 
healthy cases in CT images.  
CT dataset (Zhao et al. (2020)) 
Metric (%) DenseNet-121 ResNet-50 VGG-16 
Recall  44.0  71.2  100.0 
Precision  81.2  91.0  50.0 
AUC-ROC  86.4  64.0  51.0 
F1  58.4  81.0  71.4  
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3.3. Evaluation metrics 
The most common metrics for evaluating classification performance 





, (6)  
Recall ​ or ​ True Positive Rate = TP
TP + FN
, (7)  
False Positive Rate =
FP
FP + TN
, (8)  
where TP, TN, FP, and FN are the true positive, true negative, false 
positive, and false negative values, respectively. The F1-score is defined 
as the harmonic mean of the precision and recall, as follows 
F1 =




2TP + FP + FN
. (9)  
Besides these metrics, we have also used the AUC-ROC metric values 
(Davis and Goadrich, 2006) for evaluation. The AUC (area under the 
curve)-ROC value can be computed by integrating over the receiver 
operating characteristic (ROC) curve, plotting the true positive rate 
against the false positive rate. 
4. Implementation 
This section describes the implementation details of the proposed 
DenResCov-19 pipeline. 
4.1. Cohort details 
In order to train and validate our proposed network, we have used 
three different publicly available open-source cohorts of CXR images, 
namely, the Pediatric CXRs dataset to detect pneumonia vs healthy 
cases (Kermany et al., 2018) (source-1), the IEEE COVID-19 CXRs 
dataset (Cohen et al., 2020) (source-2), and the Tuberculosis CXRs 
from Shenzhen Hospital x-ray dataset (Jaeger et al., 2014) (source-3). 
It is important to mention that there were no multi-label cases, such as 
pneumonia and COVID-19 findings in the same patient, in any of these 
datasets. 
In order to demonstrate the adaptability of our model in multi-class 
datasets, we created four different datasets, namely DXR1, DXR2, DXR3, 
and DXR4. The DXR1 dataset was based on source-1 cohort with 3883 
pneumonia images and 1350 healthy images. This dataset is a binary 
classification dataset to detect pneumonia and healthy cases. The 
source-1 cohort is collected based on pediatric populations. Next, in 
DXR2, we have trained and tested the models for classification of 
COVID-19, pneumonia, and healthy patients in the IEEE COVID-19 x- 
rays dataset (source-2) with 69 COVID-19 images, 79 pneumonia im-
ages, and 79 healthy cases. In the third dataset (DXR3) of our study, we 
have trained and validated our network on source-2 and the tuberculosis 
(TB) cases of Shenzhen Hospital x-ray dataset (source-3) to detect TB, 
COVID-19, pneumonia, and healthy cases. As the source-3 had more 
than 300 CXR images for both TB and healthy classes, the combination 
of the two sources would end up with an unbalanced dataset. Thus, we 
randomly selected 79 tuberculosis images from source-3 and 69 COVID- 
19 images, 79 pneumonia images, and 79 healthy cases from source-2, in 
order to generate the DXR3. In the DXR4 dataset of our study, we have 
trained and validated our network on a combination of source-1, source- 
2, and source-3 to detect TB, COVID-19, pneumonia, and healthy cases. 
Only in this case, we mixed the pediatric and adult patients populations 
of the three sources, in order to test the robustness of our proposed 
model in multi-class dataset with a variation of the patient’s age. To 
avoid the bias effects, we created the dataset with randomly selected 
balanced number of images. In the healthy class, we included 110 im-
ages from each source to generate a total of 330 healthy cases. In the 
pneumonia class, we included 79 images from source-2 and 221 images 
from source-1 to generate 300 pneumonia images. Finally, 310 tuber-
culosis images source-3 and 69 COVID-19 images from source-2 were 
included to prepare the final DXR4 dataset. To the best of our knowl-
edge, there was no other COVID-19 CXR open-source dataset available, 
in order to balance the number of images in the COVID-19 class. Fig. 2 
depicts a sample of the CXR scans from the healthy, COVID-19, pneu-
monia, and tuberculosis patients, as determined by expert radiologists. 
Summarizing the four different cases:  
• DXR1: 3883 pneumonia and 1350 healthy cases (Kermany et al., 
2018). 
Fig. 1. DenResCov-19: a deep transfer learning pipeline to classify if a patient has COVID-19, pneumonia, or tuberculosis, based on CXR.  
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• DXR2: 69 COVID-19 images, 79 pneumonia images, and 79 healthy 
cases (Cohen et al., 2020).  
• DXR3: 69 COVID-19 images, 79 pneumonia images, 79 tuberculosis 
images, and 79 healthy cases (Cohen et al., 2020; Jaeger et al., 2014). 
• DXR4: 69 COVID-19 images, 300 pneumonia images, 310 tubercu-
losis images, and 330 healthy cases (Kermany et al., 2018; Cohen 
et al., 2020; Jaeger et al., 2014). 
Here, the DXR4 is simply an extended version of DXR3, generated using 
more images from the datasets of (Kermany et al., 2018; Cohen et al., 
2020; Jaeger et al., 2014). 
4.2. Cohort’s pre-processing image analysis 
Image analysis techniques have been applied on all slices to reduce 
the effect of noise and increase the signal-to-noise ratio (SNR). We have 
used noise filters such as binomial deconvolution, Landweber decon-
volution (Vonesch and Unser, 2008), and curvature anisotropic diffusion 
image filters (Perona and Malik, 1990) to reduce noise in the images. We 
have normalized the images by subtracting the mean value from each 
image and dividing by its standard deviation. Finally, we have used data 
augmentation techniques including rotation (rotation around the center 
of image by a random angle in the range of − 15∘ to 15∘), width shift 
range (width shift of image by up to 20 pixels), height shift range (height 
shift of image by up to 20 pixels), and ZCA whitening (add noise in each 
image) (Koivunen and Kostinski, 1999). 
4.3. Hyper-parameters initialization 
After random shuffling, each dataset has been partitioned into 70% 
and 30% of the total CXR images using the repeated random sub-
sampling validation technique (also known as the Monte Carlo cross- 
validation split), before training and testing the models, respectively. 
We have used the categorical cross-entropy as cost function. The loss 
function is optimized using the stochastic gradient descent (SGD) 
method with learning rate of 0.001 and with 30 epochs (the models 
converged after 20–25 epochs). We have applied transfer learning 
techniques on the ResNet-50 and DenseNet-121 networks using the 
ImageNet dataset (Deng et al., 2009) (http://www.image-net.org). It 
consists of over 14 million images and the task is to classify the images 
into one of almost 22,000 different categories (cat, sailboat, etc.). 
4.4. Software 
The code developed in this study is written in the Python program-
ming language using Keras/TensorFlow (Python) libraries. For training 
and testing of the deep learning networks, we have used an NVIDIA 
cluster, with 4 GPUs and 64 GB RAM memory. The code implementation 
is available on a public repository with url: https://github.com/team 
-globs/COVID-19_CXR. 
5. Performance analysis and discussions 
This section presents the performance of our proposed DenResCov- 
19 network, along with a quantitative performance comparison with 
established DL networks, on four different datasets. The underlying 
reason behind choosing the DenseNet-121 and ResNet-50 networks in 
our study is that we wanted to combine the advantages of both networks 
to develop a new network with well-balanced AUC-ROC and F1 metric 
values. VGG-16 is a network with relatively faster training time and, in 
the majority of cases, it has very good AUC-ROC, but comparatively poor 
F1-value. Hence, we wished to check if the performance of our network 
is superior enough from VGG, to compensate for the relatively slower 
training procedure. We preferred to choose ResNet-50 as a well- 
balanced choice regarding the training time and accuracy of the 
network, since ResNet is very fast in low layers (such as ResNet-18), but 
the accuracy improves as the layers of the structure increase (50, 110 
etc.). The same approach was followed for the DenseNet too. 
Fig. 2. A sample of healthy, COVID-19, pneumonia, and tuberculosis cases from the CXR image dataset.  
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In addition, in the study presented in Bressem et al. (2020), the DL 
structures with superior performance in classification were determined 
as ResNet, DenseNet, AlexNet, Inception, VGG, and SqueezeNet. Among 
these networks, the most superior AUC-ROC value in COVID-19 image 
data collection and CXR cohort were the ResNet-50, DenseNet-161, 
VGG-19, and AlexNet. Regarding the Area Under the Precision Recall 
Curve and Sensitivity and Specificity, the best networks were the 
ResNet-50, DenseNet-161, VGG-16, and Alex-Net. Since ResNet-50 and 
DenseNet-161 presented satisfactory performance in the majority of the 
cases, we preferred to consider them as the benchmark networks. 
However, instead of DenseNet-161, we used the DenseNet-121 due to its 
significantly less computation time during training. 
5.1. Evaluating the classification performance 
As explained in Section 4.1, we have created four different CXR 
image collections to evaluate the performance of the models in binary 
and multiclass classification. Table 2 summarizes the metrics for the 
different networks and datasets. Our initial hypothesis that our network 
DenResCov-19 will have more balanced AUC-ROC and F1 measurements 
compared to the DenseNet-121 and ResNet-50 networks, has been 
verified in all four datasets. 
In particular, DenResCov-19 has AUC-ROC of 99.60%, 96.51%, and 
95.00%, contrary to the 98.95%, 92.12%, and 93.21% of ResNet-50 and 
99.10%, 93.20%, and 91.00% of DenseNet-121 for the DXR1, DXR2, and 
DXR4 datasets, respectively. In addition, DenResCov-19 has F1 values of 
98.21%, 87.29%, and 75.75%, contrary to the 96.34%, 78.11%, and 
69.51% of ResNet-50 and 96.27%, 80.37%, and 70.07% of DenseNet- 
121 for the DXR1, DXR2, and DXR4 datasets, respectively. Our 
network has achieved more than 98% in all metrics in the binary label 
classification (pneumonia or healthy) of the DXR1 dataset. With the 
exception of the recall values in DXR2 and DXR4 datasets of VGG-16, our 
approach outperforms all other networks for all four metrics in all four 
datasets. 
From the results presented in Table 2, it is clear that as the number of 
label classes increases, the accuracies of evaluation metrics decrease. In 
our DenResCov-19 network, the recall value of 98.12% in DXR1 has 
decreased in DXR2, DXR3, and DXR4 datasets with a variation between 
59.28% and 89.38%. In a similar way, the precision value has reduced 
from 98.31% to 79.56–85.28%, AUC-ROC from 99.60% to 
91.77–96.51%, and the F1-value from 98.21% to 68.09–87.29%. How-
ever, as previously discussed, the results or our network are still better 
than the state-of-the-art networks. It should also be noted that the metric 
results in DXR4 dataset are better than the results in DXR3, although the 
numbers of label classes in two datasets are the same (COVID-19, 
pneumonia, tuberculosis, and healthy). This happens as the number of 
training data has increased from almost 80 images to almost 300 images 
per class (except for the COVID-19 cases, which remains at 69). It is 
worth mentioning that, since the number of labeled COVID-19 x-ray 
images is very limited (69 images), it has affected the quantitative re-
sults of both precision and recall values in DXR2, DXR3, and DXR4 
datasets. Incorporation of additional labeled data in future would 
significantly improve the performance with respect to these two indices. 
5.2. Evaluating the cross validation results 
For any classification task, it is very important to minimize the bias 
effects generated from a fixed validation scheme (70% training, 30% 
testing). Thus, we have compared the three networks (DenseNet-121, 
ResNet-50, and DenResCov-19) in DXR4 dataset for classification over 
four randomly shuffled fixed ratio validation schemes (also known as 
Monte Carlo cross-validation method). For each cross-validation set, we 
have calculated the F1 and AUC-ROC metrics and the ‘micro’, ‘macro’, 
and ‘weighted’ versions of the indices. The ‘micro’ version is calculated 
by counting the total number of true positives, false negatives, and false 
positives. The ‘macro’ version computes the metric for each class and 
finds their unweighted means. The ‘weighted’ version measures the 
metric for each class and determines their weighted means. Table 3 
summarizes the results of four different cross-validations in the DXR4 
dataset for the DenseNet-121, ResNet-50, and DenResCov-19 networks. 
DenResCov-19 achieves the highest score in all average, higher, and 
lower values of the metrics. DenseNet-121 has higher recall and preci-
sion average values (62.7, 79.3% against 62.0, 78.6%) and lower AUC- 
ROC (91.0 against 93.2%) as compared the ResNet-50 network. 
Fig. 3 presents the ROC curves for multi-class classification by 
ResNet-50, DenseNet-121, and DenResCov-19 networks. The ROC 
curves are computed in four different cross-validation cases in DXR4 
dataset. Based on these figures, it is clear that the true/false positive rate 
and the ROC curves’ results of the DenResCov-19 network (Fig. 3 third 
row) are much better in all classes, as compared to the other two net-
works (Fig. 3 first and second rows). From the results presented in the 
Fig. 3, we can find the average AUC-ROC values of the four classes for 
DenseNet-121, ResNet-50, and DenResCov-19 networks. The average 
AUC-ROC values of TB, COVID-19, healthy, and pneumonia classes for 
ResNet-50 are 84.8, 82.5, 92.3, 87.1%, while the same for DenseNet-121 
are 87.3, 83.1, 90.8, 89.7% and for DenResCov-19 are 94.7, 92.6, 96.4, 
95.3%, respectively. Hence, the DenseNet-121 achieves improved true/ 
false positive rate and AUC-ROC values as compared to the ResNet-50 
(except for the healthy class). On the other hand, the performance of 
DenResCov-19 is higher in all average AUC-ROC values of TB, COVID- 
19, healthy, and pneumonia classes compared to both ResNet-50 and 
DenseNet-121. 
Fig. 4 presents the confusion matrices of multi-class classification by 
the ResNet-50, DenseNet-121, and DenResCov-19 networks on DXR4 
dataset (combined over four cross-validation cases). In the ResNet-50 
network, the COVID class has 69.2% true positive and 30.8% false 
negative predictions among the total number of positive cases, com-
bined over four cross-validation iterations; while in the pneumonia 
class, the network has 92.3% true positive and 7.7% false negative 
predictions. In the TB class, the network has 80.2% true positive and 
19.8% false negative predictions, and in the healthy class 75.8% true 
positive and 24.2% false negative predictions. On the other hand, the 
DenseNet-121 has in the COVID class 70.9% true positive and 29.1% 
Table 2 
Comparative performance metrics of the different deep learning networks per-
forming classification of pneumonia, TB, COVID-19, and healthy cases. Boldface 
indicates the best metric among the networks.  
DXR1 dataset: pneumonia and healthy 
Metric DenResCov-19 DenseNet-121 ResNet-50 Inception-V3 
Recall (%) 98.12 97.80 97.71 93.32 
Precision (%) 98.31 94.62 95.01 90.10 
AUC-ROC (%) 99.60 99.10 98.95 92.80 
F1 (%) 98.21 96.27 96.34 91.68  
DXR2 dataset: COVID-19, pneumonia and healthy 
Metric DenResCov-19 DenseNet-121 ResNet-50 VGG-16 
Recall (%) 89.38 83.54 83.53 99.83 
Precision (%) 85.28 77.45 73.35 33.38 
AUC-ROC (%) 96.51 93.2 92.39 50.07 
F1 (%) 87.29 80.37 78.11 49.51  
DXR3 dataset: COVID-19, pneumonia, tuberculosis and healthy 
Metric DenResCov-19 DenseNet-121 ResNet-50 VGG-16 
Recall (%) 59.28 57.71 56.66 66.53 
Precision (%) 79.56 74.87 74.00 26.53 
AUC-ROC (%) 91.77 89.49 92.12 53.11 
F1 (%) 68.09 65.17 64.17 38.00  
DXR4 dataset: COVID-19, pneumonia, tuberculosis and healthy 
Metric DenResCov-19 DenseNet-121 ResNet-50 VGG-16 
Recall (%) 69.7 62.70 62.00 93.69 
Precision (%) 82.90 79.35 78.60 27.17 
AUC-ROC (%) 95.00 91.00 93.21 54.99 
F1 (%) 75.75 70.07 69.51 42.13  
M. Mamalakis et al.                                                                                                                                                                                                                            
Computerized Medical Imaging and Graphics 94 (2021) 102008
8
false negative predictions, in the pneumonia class 89.4% true positive 
and 10.6% false negative predictions, in the TB class 85.6% true positive 
and 14.4% false negative predictions, and in the healthy class 77.5% 
true positive and 22.5% false negative predictions. In comparison, the 
DenResCov-19 network has in the COVID class 89.5% true positive and 
10.5% false negative predictions, in the pneumonia class 96.0% true 
positive and 4.0% false negative predictions, in the TB class 94.5% true 
positive and 5.5% false negative predictions, and in the healthy class 
88.5% true positive and 11.5% false negative predictions. Based on 
these evidences, we can infer that our proposed network results in 
higher true positive and lower false negative values as compared to the 
two established networks. Detailed results for the confusion matrices of 
individual cross validation cases of the three networks are provided in 
the supplementary material. 
The quantitative performance analysis of the Monte Carlo cross- 
validation experiment for ResNet-50, DenseNet-121, and DenResCov- 
19 networks over DXR4 dataset has been presented as box-plots in  
Fig. 5. Here it is clearly visible that the proposed DenResCov-19 network 
achieves higher classification performance for all 4 classes, irrespective 
of the quantitative evaluation indices. For the statistical significance 
analysis of the classification performance of three networks in terms of 
the F1-score, precision, and recall values, the linear mixed model 
analysis has been adopted, where the four different classes, namely 
COVID-19, pneumonia, tuberculosis, and healthy patients, have been 
included as random effects in the linear mixed model. Applying the 
Kenward and Roger’s method for the degrees of freedom of the t-statistic 
(Kenward and Roger, 1997) and the Tukey’s method for pairwise 
comparisons (Tukey, 1949), we found that the proposed DenResCov-19 
network achieves statistically significantly better classification perfor-
mance than both DenseNet-121 and ResNet-50 networks in DXR4 
dataset in terms of all three quantitative evaluation indices. In terms of 
F1-score, the DenResCov-19 attains significant p-values of 6.5 ×10-9 
and 5.6 × 10-11 as compared to the DenseNet-121 and ResNet-50, 
respectively, while for the precision index, the p-values are measured 
as 0.0006 and 2.3 × 10-6 as compared to the same two networks. 
Similarly with respect to the recall values, the proposed DenResCov-19 
has attained significant p-values of 3.5 × 10-6 and 3.1 × 10-7 as 
compared to the DenseNet-121 and ResNet-50 networks, respectively. 
5.3. Heatmap analysis 
The significant results of our network can be clinically validated 
using a heatmap analysis. We test the classification behavior of the 
networks (heatmap analysis) in eight randomly selected patients. 
Table 3 
Quantitative evaluation metrics for four cross-validation cases on the DXR4 dataset (Kermany et al., 2018; Cohen et al., 2020; Jaeger et al., 2014), and the resulting 
average and standard deviation. Superscript max/min indicates the highest/lowest score among the cross validation sets.  
Classification performance of ResNet-50 in DXR4 dataset: COVID-19, pneumonia, tuberculosis and healthy 
Metric (%) Cross validation #1 Cross validation #2 Cross validation #3 Cross validation #4 Average 
Recall 62.7max  61.9 62.4 61.5min  62.0 ± 0.5 
Precision 81.0max  78.9 77.1min  77.6 78.6 ± 1.7 
AUC-ROC 94.1max  93.2 92.7 92.6min  93.2 ± 0.7 
AUC-ROC macro 89.9 89.0min  91.0max  89.5 89.9 ± 0.9 
AUC-ROC micro 88.1min  88.8 90.4max  88.8 89.0 ± 1.0 
AUC-ROC weighted 87.3min  88.4 89.6max  88.2 88.4 ± 0.9 
F1 70.7max  69.9 69.0 68.6min  69.5 ± 0.9 
F1 macro 70.7max  70.0 69.1 68.6min  69.6 ± 0.9 
F1 micro 70.5max  69.8 68.8 68.4min  69.4 ± 0.9 
F1 weighted 70.7max  70.1 69.0 68.7min  69.6 ± 0.9  
Classification performance of DenseNet-121 in DXR4 dataset: COVID-19, pneumonia, tuberculosis and healthy 
Metric (%) Cross validation #1 Cross validation #2 Cross validation #3 Cross validation #4 Average 
Recall 63.3max  62.4 62.3min  62.9 62.7 ± 0.5 
Precision 80.1 80.8max  79.3 76.8min  79.3 ± 1.7 
AUC-ROC 93.8max  91.2 89.0min  89.8 91.0 ± 2.1 
AUC-ROC macro 90.1min  92.5max  90.2 91.5 91.1 ± 1.1 
AUC-ROC micro 89.2 91.2max  88.8min  89.2 89.6 ± 1.1 
AUC-ROC weighted 88.7 90.6max  87.6 87.2min  88.5 ± 1.5 
F1 70.7max  70.4 69.8 69.2min  70.0 ± 0.6 
F1 macro 70.0max  69.6 69.0 68.3min  69.3 ± 0.7 
F1 micro 70.7max  70.4 69.8 69.2min  70.0 ± 0.6 
F1 weighted 70.4max  69.9 69.6 69.0min  69.8 ± 0.6  
Classification performance of DenResCov-19 in DXR4 dataset: COVID-19, pneumonia, tuberculosis and healthy 
Metric (%) Cross validation #1 Cross validation #2 Cross validation #3 Cross validation #4 Average 
Recall 70.0 71.0max  67.0min  70.7 69.7 ± 1.8 
Precision 80.0min  83.0 86.0max  82.6 82.9 ± 2.4 
AUC-ROC 93.9min  95.0 96.0max  95.2 95.0 ± 0.8 
AUC-ROC macro 94.7min  94.7 94.7max  94.8 95.6 ± 0.1 
AUC-ROC micro 93.9min  94.4 98.2max  93.9 95.1 ± 2.1 
AUC-ROC weighted 93.3min  94.1 98.0max  93.6 94.7 ± 1.8 
F1 75.0min  76.5max  75.3 76.2 75.8 ± 0.7 
F1 macro 76.2 77.6max  76.1min  77.1 76.7 ± 0.7 
F1 micro 74.9min  76.3max  75.3 76.2 75.6 ± 0.7 
F1 weighted 75.0min  76.5max  75.3 76.2 75.7 ± 0.7  
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DenResCov-19 outperformed the ResNet-50 and DenseNet-121 results, 
as it demonstrates the closest detection pattern with the expert (red el-
lipses in Fig. 7). This shows our network follows a more human-like 
approach and it can detect more accurate patterns of the different 
lung diseases as compared to the two other established networks. 
Fig. 6 highlights the main steps of our pipeline. The CXR image 
initializes the network. The outputs of the four blocks of ResNet-50 and 
DenseNet-121 are then concatenated. This concatenation creates four 
Fig. 3. The ROC curves for the four cross-validation cases over DXR4 dataset. Top to bottom: ResNet-50, DenseNet-121, and DenResCov-19.  
Fig. 4. Confusion matrices of the three deep learning networks on DXR4 dataset (combined over four cross-validation cases). Each blue-colored cell (i, j) in the matrix 
denotes the number (and percentage) of cases in target class i that has been classified as class j during prediction. At the right edge of each cell, the percentage of cases 
in the cell with respect to prediction class j is shown, while the bottom edge presents the percentage with respect to target class i. The last row and last column denote 
the total number (and percentage) of cases in the target and prediction classes, respectively. (For interpretation of the references to color in this figure legend, the 
reader is referred to the web version of this article.) 
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new heatmaps 56, 28, 14, and 7 (gray squares). The new heatmaps 56, 
28, and 14 pass from a convolution and average max-pool block layer 
(Conv-blockA, Conv-blockB, and Conv-blockC). The new heatmap 7 
continues in the next layer to be combined with Conv-blockC. Following 
this step, the network combines the outputs of Conv-blockA and Conv- 
blockB (A-concat) and the outputs of Conv-blockC with the new heat-
map 7 (B-concat). The last step is a concatenation of A-concat and B- 
concat to extract the Global-concat heatmap. Based on that, the model 
learns to classify the images in the supervised training tasks. Fig. 6 
demonstrates the delineation of the COVID-19 detection point, denoted 
by red ellipse, by our proposed pipeline from a CXR lung image. The 
delineated region is identical to the area of interest detected by an expert 
radiologist. Fig. 7 shows the heatmaps of DenseNet-121, ResNet-50, and 
DenResCov-19 from a total of eight classification cases of the DXR4 
dataset. In all cases of Fig. 7, we have highlighted the last heatmap layer 
of the networks. The red circles in the CXR images are the detection 
points from our expert radiologist (AS). These points are used to classify 
the disease in each CXR image. In the top figure of Fig. 7, all images are 
accurately diagnosed by the three networks. The black and red circles in 
the heatmap images denote the wrong and accurate detection points, 
respectively, with respect of the manual annotation. The extraction of 
the circle is based on a colormap threshold of 0.5. If the average number 
of the area inside the circle is higher than the threshold, then the 
detection point assumes correct (red circle); otherwise, it assumes wrong 
(black circle). In the bottom figure of Fig. 7, the DenseNet-121 accu-
rately diagnoses the last two images (green tick), but wrongly classifies 
the first two (red cross). On the other hand, the ResNet-50 accurately 
diagnoses the first two images (green tick), while wrongly classifies the 
last two (red cross). In comparison, our network diagnoses correctly all 
images except the first one. 
In the top figure of Fig. 7, the DenseNet-121 cannot detect the left 
circle annotation (black circle) in the COVID-19 CXR image. 
Fig. 5. Boxplots for the quantitative performance analysis of three deep learning networks on DXR4 dataset for the classification of COVID-19, pneumonia, 
tuberculosis, and healthy patients. 
Fig. 6. Main steps of the DenResCov-19 network to determine the classification decision, represented by heatmaps: The CXR image is the input of network, and the 
four blocks of ResNet-50 and DenseNet-121 outputs are then concatenated, creating four new heatmaps 56, 28, 14, and 7 (gray squares). The new heatmaps 56, 28, 
and 14 initialize a convolution and average max-pool block layer (Conv-blockA, Conv-blockB, and Conv-blockC), and the new heatmap 7 is used by the next layer 
without any further analysis. The network combines the Conv-blockA with the Conv-blockB outputs (A-concat), and the Conv-blockC with the new-heatmap 7 (B- 
concat). Finally, A-concat and B-concat outputs are concatenated in a Global-concat heatmap. (For interpretation of the references to color in this figure legend, the 
reader is referred to the web version of this article.) 
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Additionally, it cannot clearly detect the right circle annotation either. 
On the other hand, the ResNet-50 cannot detect the right circle anno-
tation (black circle), while it identifies the left circle. In comparison, 
DenResCov-19 can detect both circle annotations strongly. In the 
tuberculosis CXR image, the DenResCov-19 also strongly detects the 
circle annotation, while the ResNet-50 and DenseNet-121 cannot detect 
clearly the circle annotation (near the threshold). However, in the 
pneumonia CXR image, the DenseNet-121 strongly detects the red circle 
annotation, while the ResNet-50 and DenResCov-19 cannot clearly 
detect it. 
5.4. Discussions 
One important limitation of this study is the relatively small cohort 
size for patients with COVID-19. Due to this, we mixed the pediatric and 
adult patients populations of the sources-1, 2 and 3 in DXR4 dataset, in 
order to test the robustness of our proposed model in a dataset with 
larger cohort size. To avoid the bias effects, we created the dataset with 
randomly selected balanced number of images. As a result, there are 
some detected features, for example the pneumonia scars in Fig. 7 (top 
frame) or the healthy case in Fig. 7 (bottom frame) in DXR4 dataset, 
Fig. 7. Heatmap results of ResNet-50 (left), DenseNet-121 (middle) and DenResCov-19 (right). Red ellipses indicate the (human-generated) detection areas that are 
correctly identified by the network and black ellipses represent the undetected areas from the corresponding network. The successfully classified images are an-
notated with green ticks and the wrongly classified images are annotated with red crosses. (For interpretation of the references to color in this figure legend, the 
reader is referred to the web version of this article.) 
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which our pipeline cannot strongly detect. The detection of these pa-
thologies in DXR4 is more challenging and a larger dataset with addi-
tional demographics is required for further investigation. 
Another limitation of this study is the multi-label lung pathology 
task. In order to further evaluate the generalization and robustness of 
our pipeline as a whole lung multi-pathologies classifier, we need to 
provide the multi-class and multi-label classification. Although we have 
delivered the multi-class challenge in the best possible way based on the 
available published cohorts, we still face a luck of the generalization 
from the multi-label aspect. An example of multi-label sample is when a 
subject has both bacterial pneumonia and COVID-19 diseases. The main 
reason we could not deliver this aspect is the lack of any publicly 
available multi-label lung disease datasets. 
The main advantage of this study is that, in the majority of lung 
pathologies, the detection points of radiologist CXR lung images are 
identified more strongly using the DenResCov-19 network, as compared 
to the ResNet-50 and DensNet-121. The heatmap results presented in 
Figs. 6 and 7 justify the accurate classification of our network and 
validate our initial hypothesis. Moreover, all evaluation metrics of the 
different classification datasets (from DXR1 to DXR4) demonstrate the 
robustness and superior performance of the DenResCov-19 network as 
compared to the benchmark deep learning based approaches. 
As we discussed in Section 2, there are some limitations in the ma-
jority of the existing studies regarding robust and efficient detection of 
the COVID-19 and lung diseases. In our current study, we have examined 
these limitations and tried to solve them. We have trained our model 
based on regularization techniques, such as data augmentation and 
penalty L2 norms, to avoid possible overfitting. Furthermore, we have 
verified the generalization and accurate prediction of our model using 
Monte Carlo cross-validation technique. The proposed method is fully 
automated and it does not need any manual segmentation of the lung 
region from experts to deliver a robust classification result. Finally, we 
have demonstrated different applications of the model over binary and 
multi-class classification tasks. 
6. Conclusions 
In this study, we have implemented a new deep-learning network 
named DenResCov-19, which can deliver robust classification results in 
multi-class lung diseases. We have tested the proposed model over three 
different published datasets with four classes, namely, the COVID-19 
positive, pneumonia, TB, and healthy patients. We have also mitigated 
the class imbalance issue by properly composing the datasets (except for 
DXR4, where the dataset is imbalanced in COVID-19 positive class due 
to limited number of available images). Hence, based on our experi-
mental analysis, we can infer a favorable generalization and robust 
behavior of our proposed model. Our experimental analysis has 
demonstrated improved classification accuracy of our network, as 
compared to the state-of-the-art networks such as ResNet-50, DenseNet- 
121, VGG-16, and Inception-V3. Our initial hypothesis that our network 
can deliver a well-balanced AUC-ROC and F1 metric results has been 
verified. In most of the cases, the detection points of our network from 
heatmaps are in line with the detection points from the expert radiolo-
gist. To summarize, we have developed a pre-screening fast-track deci-
sion network to detect COVID-19 and other lung pathologies based on 
CXR images. 
In our future study, we will further focus on the generalization of our 
model with the availability of a significantly larger COVID-19 patients’ 
cohort. In addition, it will be beneficial to extend the number of classes 
to include more lung diseases if the corresponding datasets exist. Finally, 
we wish to evaluate the DenResCov-19 network in different datasets, in 
order to further evaluate the generalization and robustness of our 
pipeline in different medical image classification tasks, such as diag-
nosing multi-label lung diseases and other medical disease classification. 
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